Table 1 Description of sample groups and its relation to TG2 expression
From: Expression analysis of transglutaminase 2 in premalignant lesions of the cervix
HPV typing | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Histopathological analysis | Patients | Low risk | High risk | Not defined | TG2 (%) | TG2 - Image J | ||||||
n | % | n | % | n | % | n | % | n | % | |||
Control | 38 | 26.0 | 9 | 23.7 | 1 | 2.6 | 16 | 42.1 | 12 | 31.6 | 74%* (SD* 17.13) | 110,9 (SD 87.27) |
LSIL | 44 | 30.1 | 4 | 9.1 | 3 | 6.8 | 24 | 54.5 | 13 | 29.5 | 74,7%* (SD 17.55) | 80,4 (SD 66.03) |
HSIL | 32 | 21.9 | 3 | 9.4 | 3 | 9.4 | 17 | 53.1 | 9 | 28.1 | 22,3%* (SD 24.12) | 5,1 **(SD 11.67) |